Viscosupplementation for Osteoarthritis of the Knee: A Key Opinion Leader Panel Discussion

With a sharp rise in the prevalence of osteoarthritis of the knee (OAK) in a younger population, new management strategies are needed to preserve mobility, improve patients' quality of life, and reduce the effects of potential disease-related comorbidities. Viscosupplementation with the use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Bert, Jack, Kenney, Jim, Sgaglione, Nicholas A., McClelland, Scott, Brophy, Robert, Toth, John, Ruane, Joseph, Ali, Yousaf, Arquette, Sheila, Dasa, Vinod, Lopes, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2018
Materias:
Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408395/
https://www.ncbi.nlm.nih.gov/pubmed/29851537
http://dx.doi.org/10.18553/jmcp.2018.24.6-a.s2
Descripción
Sumario:With a sharp rise in the prevalence of osteoarthritis of the knee (OAK) in a younger population, new management strategies are needed to preserve mobility, improve patients' quality of life, and reduce the effects of potential disease-related comorbidities. Viscosupplementation with the use of hyaluronic acid (HA) injection is a treatment option for OAK that can provide lubrication and elastic shock absorption, leading to potential pain relief, improved function, and reduced stiffness. A key opinion leader (KOL) panel discussion was held December 3, 2016, with the objective of sharing opinions, ideas, information, and trends regarding OAK and the potential treatment and management offered by viscosupplementation. The panel concluded that viscosupplementation with HA injections presents a viable, cost-effective, and safe alternative for the treatment of OAK.

Ejemplares similares